HEALTH OF WOMAN. 2020.2(148): 25–29; doi 10.15574/HW.2020.148.25
 Benyuk V. O.¹, Korniets N. G.², Oleshko V. F.¹, Zabudskyi O. V.^1
1Bogomolets National Medical University
²SE «Luhansk State Medical University»

Intrauterine pathology is a complex of diseases, different in etiology and pathogenesis, which are associated with changes in the mucous or muscle membranes of the uterine cavity. In its structure, submucous uterine leiomyoma ranks third with a purity of 6.5%. The introduction of the hysteroresectoscopy method in gynecological practice allowed us to abandon the uterus extirpation in favor of organ-preserving surgery. Since hysteroresectoscopy is an operative intervention, as with any operation, there is a risk of complications. The world statisctics show that the frequency of complications of hysteroscopy varies between 0.4-6%.
The objective: to reduce the frequency of intraoperative and postoperative blood loss in patients with submucous uterine leiomyoma during hysteroresectoscopy.
Materials and methods. 183 women with submucous uterine leiomyoma was performed. Depending on the chosen treatment strategy, the women were divided into two groups: the main group included 76 patients who received the developed advanced diagnostic and treatment complex. The control group included 107 women, whose inpatient management was carried out in accordance with the current quality standards of medical care. In order to determine the amount of menstrual blood loss during the preoperative period and after 3 months in the operative one, all women were given a clinical interview with filling in the pictogram.
Results. The average age of studied women was 31.2±0.34 years. The duration of menstrual discharge was in the range of 7 to 10 days and averaged 9.2±0.2 days. More than half of women – 97 (53.0%) used sanitary tampons along with daily pads. The “super-heavy” volume of menstrual blood loss was typical for 10 women (5.3%). The sizes of individual leiomyoma nodes varied between 1,0 and 3,0 cm in diameter (according to the inclusion criteria) and averaged 1,82±0,29 cm, in women with leiomyoma we noted that myomatous nodes were mapped primarily in blue (dense type according to the classification). Against the background of the developed complex, the average size of leiomatous nodes in patients of the main group significantly differed from the average size of nodes in patients of the control group by an average of 66.4% (the main group – 1.62±0.29; the control group-2.44±0.21; p<0.05). Analysis of hysteroresectoscopic intervention shows that in the main group, increased blood loss that required postoperative administration of uterotonic drugs was registered in 6 (7.9%) cases (the control group – 32 (29.9%) (p<0.05).
Postoperative administration of uterotonic drugs in the main group was performed in 14 (18.4%) cases, while in the control group this value was 4.2 times higher and amounted to 82 (76.6%) cases. The “light” volume of blood loss was noted by 36 (33.7%) women in the control group and 50 (65.8%) women in the main group (p<0.05).
Conclusions. The use of a two – step approach to intraoperative and postoperative bleeding preventing by applying triptorelin acetate 3.75 mg 28 days before hysteroresectoscopy and terlipresin acetate 0.2 mg 15 minutes before hysteroresectoscopy can significantly reduce the volume of intraoperative (main group – 4 cases (5.3%), control group – 25 cases (23.4%); (p<0.05) and postoperative blood loss (main group – 6 cases (7.9%), control group – 31 cases (28.9%); (p<0.05), reduce the time of endoscopic manipulation; it also reduces the material costs associated with its implementation and also helps prevent postoperative complications.
Key words: bleeding, hysteroresectoscopy, intrauterine pathology, intra- and post-operative complications, submucous uterine leiomyoma.

REFERENCES

1. Bazanov PA, Volkov NI. 2002. Uterine fibroids and reproductive disorders. Problemy reprodukcii 8:16–18.

2. Beniuk VO, Goncharenko VM, Oleshko VF, Zabuds’kyj OV. 2019. Functional and endoscopic methods for diagnosing intrauterine pathology. Zdorov’e zhenshhiny 7(143):39–43.

3. Brehman GI, Mazorchuk BF, Masibroda NG. 2000. Uterine fibroids psychosomatic aspects, conservative treatment and prevention. K, Ivanovskaja medicinskaja akademija: 217.

4. Vdovychenko JuP, Ledin DS. 2005. Infertility in women with uterine leiomyoma. Pediatrija, akusherstvo ta ginekologija 6:89–93.

5. Danilenko VI, Malahov RV, Jagubov AS. 2005. Morphology of uterine leiomyoma. Akusherstvo i ginekologija 3:30–32.

6. Zaporozhan VM. 2014. Innovative approaches to training a modern doctor. Medychna osvita 2:38–40.

7. Krasnova IA, Breusenko VG, Kappusheva LM. 2003. Modern principles of diagnosis and surgical treatment of uterine fibroids. Akusherstvo i ginekologija 2:45–50.

8. Manusharova RA, Cherkezova JeI. 2017. Modern approaches to the treatment of uterine fibroids. Medicinskij sovet 11(12):44–53.

9. Medvedev MV. 2011. Uterine fibroids: myths and vicious practices. Z turbotoju pro zhinku 26:22–25.

10. Medvedev MV. 2011. Quantitative morphological assessment of the state of myomatous tissue and various layers of myometrium in patients with uterine leiomyoma when correcting the hormonal status using Zoladex. Morfologija 2:24–31.

11. Kirov SM. 2008. Uterine fibroids: immunological and psychosomatic concept of development, individual prognosis and management tactics. Military medical Academy. SPb.: 92–102.

12. Podol’s’kyj VV. 2016. Modern approaches to prevention and treatment of reproductive health changes in women with somatoform diseases and disorders of vegetative homeostasis. Zdorov’e zhenshhiny 10:98–101.

13. Potapov VO, Voronin KV, Medvedev MV. 2012. Evaluating the effectiveness of the algorithm for organ-preserving treatment of uterine leiomyoma. Zbirnyk naukovyh prac’ Asociacii’ akusheriv-ginekologiv Ukrainy: 338–341.

14. Potapov VO, Medvedev MV. 2014. Modern approaches to the treatment of endometrial hyperplasia in women with uterine leiomyoma. Medychni perspektyvy 19(3):23–29. https://doi.org/10.26641/2307-0404.2014.3.30340

15. Tabakman JuJu. 2013. Controversial issues of gormonoterapii hyperplasia of the endometrium. Sb. Tezisov III Obshherossijskogo seminara «Reproduktivnyj potencial Rossii: Kazanskie chtenija. Zdorove zhenshhiny – zdorove nacii». M, Iz-vo zhurnala Status Prasens:63–64.

16. Tatarchuk TF, Kosej NV, Tutchenko TN, Dzhupin VA. 2014. A new era in the treatment of uterine fibroids in women of different age groups. Reproduktyvna endokrynologija 6(20):9–20. https://doi.org/10.18370/2309-4117.2014.20.9-20

17. Tyhomyrov AL. 2006. Hysteromyoma. M, MIA:176.

18. Cheppat O. 2004. Modern principles of treatment of fibroids. Lechashhij vrach 4:76–80. https://doi.org/10.1353/sir.2006.0122

19. Campagnoli C, Berrino F, Venturelli E et al. 2013. Metformin decreases circulating androgen and estrogen levels in nondiabetic women with breast cancer. Clin Breast Cancer. 13(6):433–438. https://doi.org/10.1016/j.clbc.2013.08.012; PMid:24267731.

20. Gallos ID, Ganesan R, Gupta JK. 2013. Prediction of regression and relapse of endometrial hyperplasia with conservative therapy. Obstet Gynecol. 121(6):1165-1171. https://doi.org/10.1097/AOG.0b013e31828cb563; PMid:23812448.

21. Gkrozou  F, Dimakopoulos G, Vrekoussis T et al. 2015. Hysteroscopy in women with abnormal uterine bleeding: a metaanalysis on four major endometrial pathologies. Arch. Gynecol. Obstet. 291(6):1347–1354. https://doi.org/10.1007/s00404-014-3585-x; PMid:25524536

22. Stewart EA, Cookson CL, Gandolfo RA et al. 2017. Epidemiology of uterine fibroids: a systematic review. BJOG. 124(10):1501–1512. https://doi.org/10.1111/1471-0528.14640; PMid:28296146. Epub 2017, May 13.

23. Umranikar S, Clark TJ, Saridogan E, Miligkos D, Arambage K, Torbe E. 2016. BSGE/ESGE guideline on management of fluid distension media in operative hysteroscopy. Gynecol Surg. 13(4):289–303. https://doi.org/10.1007/s10397-016-0983-z; PMid:28003797 PMCid:PMC5133285. Epub 2016 Oct.

24. Van den Bosch T, Ameye L, Van Schoubroeck D, Bourne T, Timmerman D. 2015. Intra-cavitary uterine pathology in women with abnormal uterine bleeding: a prospective study of 1220 women. Timmerman Facts Views Vis Obgyn. 7(1):17–24.

25. Wortman M. 2016. «See-and-treat» hysteroscopy in the management of endometrial polyps. Surg. Technol. Int. 28:177–184.